Advertisement
National Provider Identifiers are vulnerable to identity theft

National Provider Identifiers Are Vulnerable to Theft

0
Providers can take steps to prevent NPI identity theft and resulting health care fraud
The incidence of preventable adverse drug events (pADEs) is zero to 17 per 1

Preventable Adverse Drug Events Usually of Minor Severity in Kids

0
Incidence of pADEs is zero to 17 per 1,000 patient-days for children in general pediatric wards
Potential side effects of biological agents may increase anxiety in patients with rheumatic disease

Side Effects of Biologics for Rheumatic Dz May Up Anxiety

0
Common patient concerns are risks of cancer and tuberculosis activation
The American Medical Association encourages patient education to raise awareness of the risks associated with opioid use after a prolonged period of sobriety

Patient Education Urged to Prevent Opioid OD After Sobriety

0
Airlines also encouraged to include naloxone in emergency medical kits
The expiration dates of certain batches of EpiPens have been extended by the U.S. Food and Drug Administration in an effort to reduce shortages of the life-saving devices.

FDA Extends EpiPen Expiration Dates to Tackle Shortage

0
Shortages due to factors such as supply disruptions and manufacturer issues
Many low-income urban preschool-aged children with asthma do not meet the criteria for home medication readiness

Many Children With Asthma Do Not Have Medications Ready

0
Low-income urban preschoolers with asthma may not meet home medication readiness criteria
Life expectancy has declined in recent years in some high-income countries

Declines in Life Expectancy in Many High-Income Countries

0
And increase in midlife death rates across racial and ethnic groups in the United States
Knowing payer policies and regulatory requirements is critical to appealing denials

Experts Offer Tips for Provider Appeal of Denied Medical Claims

0
Recommendations include asking for exceptions to payer policies and citing regulatory information
Concomitant exposure to pregabalin and opioids is associated with increased odds of opioid-related death

Odds of Death Up With Exposure to Pregabalin, Opioids

0
Dose-response association with highest odds of opioid-related death with high-dose pregabalin
From 2014 to 2017 there was an increase in tianeptine exposure calls reported by poison control centers to the National Poison Data System

CDC: Increase in Tianeptine Exposures From 2014 to 2017

0
Most commonly reported health effects were neurologic, cardiovascular, and gastrointestinal